Cargando…
Doxorubicin-Induced Translocation of mtDNA into the Nuclear Genome of Human Lymphocytes Detected Using a Molecular-Cytogenetic Approach
Translocation of mtDNA in the nuclear genome is an ongoing process that contributes to the development of pathological conditions in humans. However, the causal factors of this biological phenomenon in human cells are poorly studied. Here we analyzed mtDNA insertions in the nuclear genome of human l...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589397/ https://www.ncbi.nlm.nih.gov/pubmed/33080837 http://dx.doi.org/10.3390/ijms21207690 |
_version_ | 1783600569599918080 |
---|---|
author | Harutyunyan, Tigran Al-Rikabi, Ahmed Sargsyan, Anzhela Hovhannisyan, Galina Aroutiounian, Rouben Liehr, Thomas |
author_facet | Harutyunyan, Tigran Al-Rikabi, Ahmed Sargsyan, Anzhela Hovhannisyan, Galina Aroutiounian, Rouben Liehr, Thomas |
author_sort | Harutyunyan, Tigran |
collection | PubMed |
description | Translocation of mtDNA in the nuclear genome is an ongoing process that contributes to the development of pathological conditions in humans. However, the causal factors of this biological phenomenon in human cells are poorly studied. Here we analyzed mtDNA insertions in the nuclear genome of human lymphocytes after in vitro treatment with doxorubicin (DOX) using a fluorescence in situ hybridization (FISH) technique. The number of mtDNA insertions positively correlated with the number of DOX-induced micronuclei, suggesting that DOX-induced chromosome breaks contribute to insertion events. Analysis of the odds ratios (OR) revealed that DOX at concentrations of 0.025 and 0.035 µg/mL significantly increases the rate of mtDNA insertions (OR: 3.53 (95% CI: 1.42–8.76, p < 0.05) and 3.02 (95% CI: 1.19–7.62, p < 0.05), respectively). Analysis of the distribution of mtDNA insertions in the genome revealed that DOX-induced mtDNA insertions are more frequent in larger chromosomes, which are more prone to the damaging action of DOX. Overall, our data suggest that DOX-induced chromosome damage can be a causal factor for insertions of mtDNA in the nuclear genome of human lymphocytes. It can be assumed that the impact of a large number of external and internal mutagenic factors contributes significantly to the origin and amount of mtDNA in nuclear genomes. |
format | Online Article Text |
id | pubmed-7589397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75893972020-10-29 Doxorubicin-Induced Translocation of mtDNA into the Nuclear Genome of Human Lymphocytes Detected Using a Molecular-Cytogenetic Approach Harutyunyan, Tigran Al-Rikabi, Ahmed Sargsyan, Anzhela Hovhannisyan, Galina Aroutiounian, Rouben Liehr, Thomas Int J Mol Sci Article Translocation of mtDNA in the nuclear genome is an ongoing process that contributes to the development of pathological conditions in humans. However, the causal factors of this biological phenomenon in human cells are poorly studied. Here we analyzed mtDNA insertions in the nuclear genome of human lymphocytes after in vitro treatment with doxorubicin (DOX) using a fluorescence in situ hybridization (FISH) technique. The number of mtDNA insertions positively correlated with the number of DOX-induced micronuclei, suggesting that DOX-induced chromosome breaks contribute to insertion events. Analysis of the odds ratios (OR) revealed that DOX at concentrations of 0.025 and 0.035 µg/mL significantly increases the rate of mtDNA insertions (OR: 3.53 (95% CI: 1.42–8.76, p < 0.05) and 3.02 (95% CI: 1.19–7.62, p < 0.05), respectively). Analysis of the distribution of mtDNA insertions in the genome revealed that DOX-induced mtDNA insertions are more frequent in larger chromosomes, which are more prone to the damaging action of DOX. Overall, our data suggest that DOX-induced chromosome damage can be a causal factor for insertions of mtDNA in the nuclear genome of human lymphocytes. It can be assumed that the impact of a large number of external and internal mutagenic factors contributes significantly to the origin and amount of mtDNA in nuclear genomes. MDPI 2020-10-17 /pmc/articles/PMC7589397/ /pubmed/33080837 http://dx.doi.org/10.3390/ijms21207690 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Harutyunyan, Tigran Al-Rikabi, Ahmed Sargsyan, Anzhela Hovhannisyan, Galina Aroutiounian, Rouben Liehr, Thomas Doxorubicin-Induced Translocation of mtDNA into the Nuclear Genome of Human Lymphocytes Detected Using a Molecular-Cytogenetic Approach |
title | Doxorubicin-Induced Translocation of mtDNA into the Nuclear Genome of Human Lymphocytes Detected Using a Molecular-Cytogenetic Approach |
title_full | Doxorubicin-Induced Translocation of mtDNA into the Nuclear Genome of Human Lymphocytes Detected Using a Molecular-Cytogenetic Approach |
title_fullStr | Doxorubicin-Induced Translocation of mtDNA into the Nuclear Genome of Human Lymphocytes Detected Using a Molecular-Cytogenetic Approach |
title_full_unstemmed | Doxorubicin-Induced Translocation of mtDNA into the Nuclear Genome of Human Lymphocytes Detected Using a Molecular-Cytogenetic Approach |
title_short | Doxorubicin-Induced Translocation of mtDNA into the Nuclear Genome of Human Lymphocytes Detected Using a Molecular-Cytogenetic Approach |
title_sort | doxorubicin-induced translocation of mtdna into the nuclear genome of human lymphocytes detected using a molecular-cytogenetic approach |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589397/ https://www.ncbi.nlm.nih.gov/pubmed/33080837 http://dx.doi.org/10.3390/ijms21207690 |
work_keys_str_mv | AT harutyunyantigran doxorubicininducedtranslocationofmtdnaintothenucleargenomeofhumanlymphocytesdetectedusingamolecularcytogeneticapproach AT alrikabiahmed doxorubicininducedtranslocationofmtdnaintothenucleargenomeofhumanlymphocytesdetectedusingamolecularcytogeneticapproach AT sargsyananzhela doxorubicininducedtranslocationofmtdnaintothenucleargenomeofhumanlymphocytesdetectedusingamolecularcytogeneticapproach AT hovhannisyangalina doxorubicininducedtranslocationofmtdnaintothenucleargenomeofhumanlymphocytesdetectedusingamolecularcytogeneticapproach AT aroutiounianrouben doxorubicininducedtranslocationofmtdnaintothenucleargenomeofhumanlymphocytesdetectedusingamolecularcytogeneticapproach AT liehrthomas doxorubicininducedtranslocationofmtdnaintothenucleargenomeofhumanlymphocytesdetectedusingamolecularcytogeneticapproach |